Search results
Results from the WOW.Com Content Network
The following table lists the largest biotechnology and pharmaceutical companies ranked by revenue in billion USD. The change column indicates the company's relative position in this list compared to its relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.
The following table lists the largest biotechnology and pharmaceutical companies ranked by market capitalization in billion US dollars. The change column indicates the company's relative position in this list compared to their relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.
These business groups provide fluid management products and systems to customers in biotechnology, pharmaceutical, transfusion medicine, energy, electronics, municipal and industrial water purification, aerospace, transportation and broad industrial markets. The company was founded by David B. Pall in 1946 as Micro Metallic Corporation. [12]
These two could become direct competitors relatively soon.
CSRA Inc. will be added to the S&P 500 reflecting its spin-off from Computer Sciences. CSC will be removed from the S&P 500. [279] November 18, 2015: GNW: Genworth Financial: ROVI: Rovi: Synchrony Financial (NYSE:SYF) replaced Genworth Financial Inc. in the S&P 500. [280] November 2, 2015: MKTX: MarketAxess Holdings: CYN: City National Corp
The New York City Economic Development Corporation's Early Stage Life Sciences Funding Initiative and venture capital partners, including Celgene, General Electric Ventures, and Eli Lilly, committed a minimum of US$100 million to help launch 15 to 20 ventures in life sciences and biotechnology in 2014, [6] and in January 2018, the City of New ...
On May 5, 2017, it was announced that Avantor, a Center Valley, Pennsylvania-based supplier of ultra-high-purity materials to the life sciences and advanced technology industries, would acquire VWR for $33.25 in cash per share of VWR common stock, reflecting an enterprise value of approximately $6.4 billion.
The S&P 500 fell 0.2% to extend the four-day losing streak that dimmed the close of its stellar 2024. The Dow Jones Industrial Average fell 151 points, or 0.4%, after an early gain of 360 points ...